Apr 13, 2022

New Initiatives Awarded $4.7 Million to Encourage COVID-19 Testing in Underserved Communities and Schools

In their quest to overcome health disparities, University of Utah Health scientists are launching SCALE-UP II and SCALE-UP Counts, a pair of initiatives designed to increase COVID-19 testing and vaccination among rural and underserved populations. Combined, the two initiatives are supported by $4.7 million from the National Institutes of Health (NIH).

Apr 13, 2022

Pancreatic Cancer Action Network Adaptive Clinical Trial Adds New Investigational Treatment and Additional Sites

The Pancreatic Cancer Action Network has announced the latest updates to its innovative adaptive clinical trial, Precision PromiseSM, including the addition of an investigational treatment from global healthcare company, Novartis, as well as the opening of five additional sites across the country, including at Huntsman Cancer Institute.

Apr 07, 2022

American Cancer Society Awards $50,000 to Transportation Needs for Cancer Patients

Huntsman Cancer Institute awarded $50,000 by American Cancer Society to fund transportation and lodging for cancer patients and their loved ones. Amy Horyna, MSW, says, "This gift will make a huge difference by allowing us to deliver assistance directly to patients who need it most."

Mar 28, 2022

Recognized as Leader in LGBTQ+ Healthcare Equality by Human Rights Campaign

The LGBTQ+ Healthcare Equality Leader designation highlights Huntsman Cancer Institute’s commitment to equity, diversity, and inclusion, and its work to foster a culture of belonging for all, including those who identify as LGBTQ+.

Mar 14, 2022

Ashlee Harrison, MPA, Announced as Executive Director of Innovation and Transformation

Huntsman Cancer Institute announces Ashlee Harrison, MPA, as executive director of innovation and transformation. The Innovation and Transformation Office supports Huntsman Cancer Institute in taking on new challenges with agility and accelerating progress toward a cancer-free frontier.

Feb 28, 2022

Research Team Outlines New Methods to Identify Personalized Drug Treatments for Breast Cancer

Researchers at Huntsman Cancer Institute are developing breast cancer models using tumors donated by patients to narrow the number of drugs that might be effective in each tumor based on the unique characteristics and behavior in these models of cancer.

Feb 03, 2022

Clinical Trial Hopes to Shed New Light on Glioblastoma

Huntsman Cancer Institute at the University of Utah is one of the select sites in the United States to offer a new clinical trial for glioblastoma patients, called GBM AGILE. The clinical trial is using an approach that offers study participants multiple new glioblastoma drugs from different pharmaceutical companies.

Feb 02, 2022

International Study of Colorectal Cancer Receives Five-Year Renewal, $10 Million in New Funding to Continue Innovative Research

The ColoCare Study, a major international study of colorectal cancer, has received a five-year renewal and $10 million to fund colorectal cancer treatment innovations. This next phase of the project will use research findings from the ColoCare Study to develop new medical interventions.